AMAG Pharmaceuticals, Inc. to Present at the 24th Annual ROTH Conference

LEXINGTON, Mass.–(BUSINESS WIRE)–Mar. 2, 2012–
AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that company
management will participate at the 24^th Annual ROTH
Conference on March 13 at 4:30 pm PT in Dana Point, CA. Company
management will provide an overview of the company followed by a
question and answer period with investors.

A live webcast of the presentation will be accessible through the
Investors section of the Company’s website at www.amagpharma.com.
Following the conference, the webcast will be archived on the AMAG
Pharmaceuticals, Inc. website until April 13, 2012.

About AMAG Pharmaceuticals, Inc.

AMAG Pharmaceuticals, Inc. is a biopharmaceutical company focused on the
development and commercialization of a therapeutic iron compound to
treat iron deficiency anemia. For additional company information, please
visit www.amagpharma.com.

Source: AMAG Pharmaceuticals, Inc.

AMAG Pharmaceuticals, Inc.
Amy Sullivan, 617-498-3303